Mail

UK markets open in 1 hour 5 minutes

NIKKEI 225
38,184.62
+222.82(+0.59%)
HANG SENG
16,400.07
+148.23(+0.91%)
CRUDE OIL
82.87
+0.18(+0.22%)
GOLD FUTURES
2,390.90
+2.50(+0.10%)
DOW
37,753.31
-45.66(-0.12%)
Bitcoin GBP
49,231.74
-2,027.24(-3.95%)

5 ways to get help with childcare costs

Childcare is eye-wateringly expensive, here are some ways to save money

Intech Biopharm Corporation (6461.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD

Add to watchlist

27.90

+0.15

(+0.54%)

At close: 01:30PM CST

Currency in TWD

Valuation measures⁴

Market cap (intra-day)	3.81B
Enterprise value	4.65B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	129.33
Price/book (mrq)	3.27
Enterprise value/revenue	179.91
Enterprise value/EBITDA	-21.18

Trading information

Stock price history

Beta (5Y monthly)	0.37
52-week change ³	-19.44%
S&P500 52-week change ³	21.61%
52-week high ³	37.37
52-week low ³	24.00
50-day moving average ³	28.68
200-day moving average ³	28.26

Share statistics

Avg vol (3-month) ³	165.74k
Avg vol (10-day) ³	162.3k
Shares outstanding ⁵	137.41M
Implied shares outstanding ⁶	138.14M
Float ⁸	N/A
% held by insiders ¹	43.93%
% held by institutions ¹	6.04%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-1,732.39%

Management effectiveness

Return on assets (ttm)	-7.61%
Return on equity (ttm)	-30.73%

Income statement

Revenue (ttm)	25.85M
Revenue per share (ttm)	0.22
Quarterly revenue growth (yoy)	29.00%
Gross profit (ttm)	N/A
EBITDA	-235.74M
Net income avi to common (ttm)	-337.99M
Diluted EPS (ttm)	-2.81
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	597.73M
Total cash per share (mrq)	4.35
Total debt (mrq)	1.44B
Total debt/equity (mrq)	122.88%
Current ratio (mrq)	1.22
Book value per share (mrq)	8.50

Cash flow statement

Operating cash flow (ttm)	-204.13M
Levered free cash flow (ttm)	-150.09M